Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SELECT: Raltegravir vs NRTIs in Second-Line HIV Therapy
NCT01352715Phase 3Completed
- Start
- Mar 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 3, randomised, open-label trial of raltegravir in human immunodeficiency virus type 1 infection (HIV-1). Started Mar 2012; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01352715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01352715.